 I'm Kinsey Grant and I'm here with Chris Bunker, the CEO of Lexaria. So Mr. Bunker, can you tell me a little bit more about what your company does? Absolutely. We're a biotech company and we've developed some really groundbreaking technology for the delivery of APIs or active pharmaceutical ingredients like some of the ingredients in cannabis, vitamins, non-store, anti-inflammatories, and even nicotine. Okay, so I kind of want to touch on this hot topic here, cannabis. What's the market potential like in your experience of this growing legality and of you know medical delivery of cannabis? Absolutely. The cannabis market is really exploding worldwide. This is not just an American phenomenon. It's happening in Canada and Mexico, Germany, Australia, all over the world really. And it is a market that's expected to be in the 30 to 50 billion dollar range in the next three or four years. So it's a it's a fairly big market and it's growing very very rapidly. And so what is Lexaria doing to kind of capitalize on this growing phenomenon here? Well because our technology is so groundbreaking and we effectively help cannabinoids to get into your bloodstream more rapidly and more efficiently than the otherwise can, we developed this technology. We're really an R&D company and then we license it off to other companies that have expertise in developing consumer products or cannabis related products and then they utilize our technology to make those products better.